Breaking news – Pagina 19 – AMD

Breaking news

Novembre 17, 2025 Alice Lione

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial

Ziegler AG, Achenbach P, Weiß A, et al.
Lancet. Pub. online 11 Nov 2025.

Leggi

Novembre 17, 2025 Alice Lione

INHALE-1: a multicenter randomized trial of inhaled technosphere insulin in children with type 1 diabetes

Haller MJ, Kanapka L, Monzavi R, et al.
Diabetes Care. Pub. online 12 Nov 2025.

Leggi

Novembre 17, 2025 Alice Lione

Association of HbA1c and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study

Shah VN, Xu Y, Dabiri Y, et al.
Diabetologia. Pub. online 11 Nov 2025.

Leggi

Novembre 14, 2025 Alice Lione

AIFA: Rapporto OsMed 2024 sull’uso dei farmaci in Italia

10 novembre 2025

Leggi

Novembre 13, 2025 Alice Lione

The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group

Resi V, Bianchi C, Burlina S, et al.
Acta Diabetol. Pub. online 10 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection

Jansz TT, Young KG, Hopkins R, et al.
Diabetologia. Pub. online 9 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Toward disease-modifying therapies in type 1 diabetes: focus on teplizumab

Mathieu C, Sims EK, Chatenoud L, et al.
Diabetes Care. Pub. online 6 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Hemoglobin A1c time-in-range, mortality, and diabetes complications in older adults with diabetes

Conlin PR, Prentice JC, Mohr DC, et al.
BMJ Open Diabetes Res Care. Pub. online 4 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Lantidra (donislecel) in type 1 diabetes: an in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy

Erbasan E, Aliciaslan M, Erendor F, et al.
Diabet Med. Pub. online 11 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: a population-based cohort study in England

Astbury NM, Ripullone K, Ramakrishnan R, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2025.

Leggi